In the breast cancer cell line MDA-MB-453, intracellular CDK4 activity was functionally inhibited during the treatment phase, as observed by the complete depletion of pRb (Ser780) regardless of treatment (Supplementary Figure 2B). The gene discussed is CDK4; the disease is breast cancer.